Michelle R Longmire, MD
Dermatology · Saratoga
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 5 carriers
- Offices
- 2
Offices
2 locations · Csi Medical Group · 104 clinicians in this group
Looking this up.
Plans that list them
24 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Longmire’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A119812 · Current
Licensed to practise in California · since 2012 · expires 2027-10-31 · University of New Mexico School of Medicine. Board flags: Citation Resolved.
Public record actions
| 2025-06-04 | Citation | Section 1338(c) of Title 16, California Code of Regulations · $1,000 · resolved 2025-07-14 |
Original Medicare doctor bills
$3,098
Medicare paid this office $3,098 for 17 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of skin lesions | 14 | More than 61% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
17 Original Medicare patients in 2024. Average age 74 · Health risk score 0.56. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
The office billed $7,253, Medicare allowed $4,607 and paid $3,098; for 69 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 17 | 69 | 74 | 0.56 | $7,253 | $3,098 |
| 2023 | 17 | 104 | 76 | 0.55 | $10,328 | $4,222 |
| 2022 | 12 | 49 | 77 | 0.51 | $6,430 | $2,651 |
| 2021 | 20 | 72 | 76 | 1.00 | $7,685 | $3,253 |
| 2020 | 30 | 122 | 77 | 0.71 | $12,233 | $4,733 |
| 2019 | 52 | 272 | 75 | 0.78 | $30,024 | $12,268 |
| 2018 | 81 | 444 | 76 | 0.91 | $51,418 | $20,606 |
| 2017 | 112 | 736 | 78 | 0.90 | $87,322 | $35,934 |
| 2016 | 187 | 1,147 | 75 | 1.02 | $157,226 | $62,473 |
| 2015 | 172 | 1,072 | 75 | 0.99 | $121,779 | $45,935 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2021: 1 service
| Destruction of precancer skin growth, 1 growth | 11 | $785 | $49 |
2020: 3 services
| Destruction of skin growth, 1-14 growths | 11 | $1,578 | $105 |
| Return visit (30+ min) | 16 | $1,339 | $74 |
| Destruction of precancer skin growth, 1 growth | 14 | $1,073 | $51 |
2019: 4 services
| Return visit (30+ min) | 36 | $3,789 | $79 |
| Destruction of skin growth, 1-14 growths | 26 | $3,564 | $94 |
| Destruction of precancer skin growth, 1 growth | 30 | $2,559 | $43 |
| Destruction of precancer skin growth, 2-14 growths | 24 | $536 | $5 |
2018: 4 services
| Return visit (30+ min) | 64 | $8,737 | $85 |
| Destruction of skin growth, 1-14 growths | 38 | $5,353 | $105 |
| Destruction of precancer skin growth, 1 growth | 47 | $4,127 | $49 |
| Destruction of precancer skin growth, 2-14 growths | 37 | $890 | $5 |
2017: 6 services
| Return visit (30+ min) | 90 | $14,102 | $91 |
| Destruction of skin growth, 1-14 growths | 63 | $12,056 | $109 |
| Destruction of precancer skin growth, 1 growth | 60 | $3,975 | $39 |
| Destruction of precancer skin growth, 2-14 growths | 53 | $1,678 | $6 |
| New patient visit (30+ min) | 16 | $1,224 | $76 |
| Biopsy of single growth of skin and/or tissue | 13 | $1,142 | $82 |
2016: 10 services
| Return visit (30+ min) | 145 | $22,945 | $87 |
| Destruction of skin growth, 1-14 growths | 101 | $15,923 | $100 |
| Destruction of precancer skin growth, 1 growth | 99 | $5,846 | $39 |
| Destruction of precancer skin growth, 15 or more growths | 20 | $3,283 | $137 |
| Destruction of precancer skin growth, 2-14 growths | 90 | $2,273 | $5 |
| New patient visit (45+ min) | 11 | $1,372 | $125 |
| New patient visit (30+ min) | 14 | $872 | $62 |
| Short return visit (20+ min) | 18 | $825 | $43 |
| Injection into skin growth, 1-7 growths | 11 | $454 | $41 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $15 | None |
2015: 8 services
| Destruction of skin growth, 1-14 growths | 92 | $13,333 | $105 |
| Short return visit (20+ min) | 85 | $7,988 | $65 |
| Destruction of precancer skin growth, 1 growth | 94 | $4,554 | $38 |
| Return visit (30+ min) | 40 | $4,521 | $100 |
| Destruction of precancer skin growth, 15 or more growths | 16 | $3,020 | $144 |
| Destruction of precancer skin growth, 2-14 growths | 85 | $2,525 | $6 |
| Short return visit (20+ min) | 21 | $1,592 | $41 |
| New patient visit (15+ min) | 12 | $682 | $57 |
Money from drug and device companies
$18 in 2025
| 2025 | 1 | 1 | None | $18 |
| 2023 | 4 | 4 | None | $196 |
| 2022 | 1 | 2 | None | $33 |
| 2021 | 2 | 3 | None | $78 |
| 2020 | 2 | 3 | None | $49 |
| 2019 | 3 | 4 | $2,800 | $2,998 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $18 | 1 payment
|
See the published payment
| Janssen Biotech | Meals · 2025-08-15 | Tremfya | $18 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $196
| Regeneron Pharmaceuticals | None | $139 | 1 payment
|
| Abbvie | None | $26 | 1 payment
|
| Genzyme | Dupixent | $18 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $13 | 1 payment
|
2022: $33
| Novartis Pharmaceuticals | Cosentyx | $33 | 2 payments
|
2021: $78
| Novartis Pharmaceuticals | Cosentyx | $44 | 2 payments
|
| Lilly USA | Taltz | $34 | 1 payment
|
2020: $49
| Novartis Pharmaceuticals | Cosentyx | $29 | 2 payments
|
| Janssen Biotech | Tremfya | $20 | 1 payment
|
2019: $2,998
| Merck Sharp & Dohme | None | $2,950 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $25 | 1 payment
|
| Ucb | Cimzia | $23 | 1 payment
|
Professional record
- NPI
- 1659691723
- Licence
- CA A119812California A119812: Current · expires 2027-10-31
- Trained
- University of New Mexico School of Medicine, 2010
- Group
- Csi Medical Group
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-06-10
- NPI last updated
- 2015-03-16
This is when the NPI record was last certified, not a medical board exam.